Ad
RX:CC Quote Trading Chart Biosyent Inc.
home / stock / rx:cc / rx:cc quote
Quote | Biosyent Inc. (TSXVC:RX:CC)
| Last: | $9.15 |
|---|---|
| Change Percent: | -0.65% |
| Open: | $9.19 |
| Close: | $9.15 |
| High: | $9.19 |
| Low: | $9.15 |
| Volume: | 1,602 |
| Last Trade Date Time: | 05/06/2022 04:56:26 pm |
Quotes are delayed by 15 to 20 minutes.
RX:CC Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $9.15 | $9.19 | $9.15 | $9.19 | $9.15 | 1,602 | 05-06-2022 |
| $9.21 | $9.21 | $9.21 | $9.21 | $9.21 | 2,261 | 05-05-2022 |
| $9.15 | $9.02 | $9.15 | $9.15 | $9.01 | 1,348 | 05-04-2022 |
| $9.02 | $9.03 | $9.02 | $9.1 | $9.02 | 3,543 | 05-03-2022 |
| $9.11 | $9.2 | $9.11 | $9.21 | $9.02 | 2,753 | 05-02-2022 |
| $9.2 | $9.17 | $9.2 | $9.2 | $9.12 | 781 | 04-29-2022 |
| $9.06 | $9.1 | $9.06 | $9.2 | $9.06 | 1,801 | 04-28-2022 |
| $9.11 | $9.15 | $9.11 | $9.25 | $9.1 | 2,379 | 04-27-2022 |
| $9.21 | $9.16 | $9.21 | $9.21 | $9.15 | 1,679 | 04-26-2022 |
| $9.2 | $9.2 | $9.2 | $9.2 | $9.16 | 1,074 | 04-25-2022 |
| $9.2 | $9.55 | $9.2 | $9.55 | $9.2 | 5,189 | 04-22-2022 |
| $9.57 | $9.55 | $9.57 | $9.57 | $9.51 | 4,200 | 04-21-2022 |
| $9.55 | $9.7 | $9.55 | $9.7 | $9.55 | 2,425 | 04-20-2022 |
| $9.7 | $9.75 | $9.7 | $9.75 | $9.57 | 1,938 | 04-19-2022 |
| $9.77 | $9.75 | $9.77 | $9.77 | $9.7 | 1,156 | 04-18-2022 |
| $9.9 | $9.81 | $9.9 | $9.9 | $9.7 | 9,969 | 04-15-2022 |
| $9.9 | $9.81 | $9.9 | $9.9 | $9.7 | 9,429 | 04-14-2022 |
| $9.9 | $9.94 | $9.9 | $10 | $9.85 | 9,618 | 04-13-2022 |
| $9.83 | $9.78 | $9.83 | $9.83 | $9.7 | 1,711 | 04-12-2022 |
| $9.79 | $9.6 | $9.79 | $9.79 | $9.6 | 3,051 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Biosyent Inc. Company Name:
RX:CC Stock Symbol:
TSXVC Market:
-0.65% G/L:
$9.15 Last:
1,602 Volume:
$9.19 Open:
$9.15 Close:
Biosyent Inc. Website:
Ad
-
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: Return on Equity for FY 2024 was 21% as com...
-
Sparta Capital Ltd. (SAY:CA) is expected to report for quarter end 2024-12-31 BioSyent Inc. (RX:CA) is expected to report $0.15 for Q4 2024 Headwater Exploration Inc. (HWX:CA) is expected to report $0.2 for Q4 2024 Enterprise Group Inc. (E:CA) is expected to report for Q4 2024 Den...
-
MISSISSAUGA, Ontario, March 06, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2024 on Thursday, March 13, 2025 after market hours. A pres...